Zhong Chao Han
Voorzitter bij Tianjin Amcellgene Engineering Co., Ltd.
Actieve functies van Zhong Chao Han
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Tianjin Amcellgene Engineering Co., Ltd.
Tianjin Amcellgene Engineering Co., Ltd. BiotechnologyHealth Technology Tianjin Amcellgene Engineering Co., Ltd. engages in the research and development of cell therapeutic products. It offers human adipose-derived, human umbilical cord, and human amniotic membrane-derived mesenchymal stem cells. The company was founded in August 2004 and is headquartered in Tianjin, China. | Voorzitter | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - | |
Beijing Health & Biotech Co., Ltd.
Beijing Health & Biotech Co., Ltd. BiotechnologyHealth Technology Beijing Health & Biotech Co., Ltd. engages in the development of stem cell technologies. Its business offers diabetes therapy, cardiovascular diseases therapy, neurological diseases therapy, autoimmune diseases therapy, limb ischemic disease therapy, sub-health and anti-aging therapy, and stem cell banking. The company was founded on January 8, 2007 and is headquartered in Beijing, China. | Voorzitter | - | - |
Loopbaan van Zhong Chao Han
Statistieken
Internationaal
China | 3 |
Operationeel
Chairman | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Tianjin Amcellgene Engineering Co., Ltd.
Tianjin Amcellgene Engineering Co., Ltd. BiotechnologyHealth Technology Tianjin Amcellgene Engineering Co., Ltd. engages in the research and development of cell therapeutic products. It offers human adipose-derived, human umbilical cord, and human amniotic membrane-derived mesenchymal stem cells. The company was founded in August 2004 and is headquartered in Tianjin, China. | Health Technology |
Beijing Health & Biotech Co., Ltd.
Beijing Health & Biotech Co., Ltd. BiotechnologyHealth Technology Beijing Health & Biotech Co., Ltd. engages in the development of stem cell technologies. Its business offers diabetes therapy, cardiovascular diseases therapy, neurological diseases therapy, autoimmune diseases therapy, limb ischemic disease therapy, sub-health and anti-aging therapy, and stem cell banking. The company was founded on January 8, 2007 and is headquartered in Beijing, China. | Health Technology |
- Beurs
- Insiders
- Zhong Chao Han
- Ervaring